Annual Revenue
$82.71 M
+$18.36 M+28.52%
31 December 2023
Summary:
UroGen Pharma annual revenue is currently $82.71 million, with the most recent change of +$18.36 million (+28.52%) on 31 December 2023. During the last 3 years, it has risen by +$70.91 million (+601.02%). URGN annual revenue is now at all-time high.URGN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$25.20 M
+$3.36 M+15.36%
30 September 2024
Summary:
UroGen Pharma quarterly revenue is currently $25.20 million, with the most recent change of +$3.36 million (+15.36%) on 30 September 2024. Over the past year, it has increased by +$4.35 million (+20.87%). URGN quarterly revenue is now at all-time high.URGN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$89.36 M
+$4.35 M+5.12%
30 September 2024
Summary:
UroGen Pharma TTM revenue is currently $89.36 million, with the most recent change of +$4.35 million (+5.12%) on 30 September 2024. Over the past year, it has increased by +$12.09 million (+15.64%). URGN TTM revenue is now at all-time high.URGN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.5% | +20.9% | +15.6% |
| 3 y3 years | +601.0% | +122.0% | +124.3% |
| 5 y5 years | +7232.7% | - | - |
URGN Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +601.0% | at high | +122.0% | at high | +124.3% |
| 5 y | 5 years | at high | >+9999.0% | at high | +6675.3% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
UroGen Pharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $25.20 M(+15.4%) | $89.36 M(+5.1%) |
| June 2024 | - | $21.85 M(+16.3%) | $85.01 M(+0.8%) |
| Mar 2024 | - | $18.78 M(-20.2%) | $84.30 M(+1.9%) |
| Dec 2023 | $82.71 M(+28.5%) | $23.53 M(+12.8%) | $82.71 M(+7.0%) |
| Sept 2023 | - | $20.85 M(-1.4%) | $77.28 M(+6.6%) |
| June 2023 | - | $21.14 M(+23.0%) | $72.52 M(+6.7%) |
| Mar 2023 | - | $17.19 M(-5.0%) | $67.98 M(+5.6%) |
| Dec 2022 | $64.36 M(+34.0%) | $18.09 M(+12.4%) | $64.36 M(+3.1%) |
| Sept 2022 | - | $16.10 M(-3.1%) | $62.44 M(+8.2%) |
| June 2022 | - | $16.60 M(+22.4%) | $57.69 M(+6.6%) |
| Mar 2022 | - | $13.56 M(-16.1%) | $54.12 M(+12.7%) |
| Dec 2021 | $48.04 M | $16.17 M(+42.5%) | $48.04 M(+20.6%) |
| Sept 2021 | - | $11.35 M(-12.9%) | $39.83 M(+24.7%) |
| June 2021 | - | $13.03 M(+74.1%) | $31.94 M(+65.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $7.49 M(-6.0%) | $19.28 M(+63.4%) |
| Dec 2020 | $11.80 M(>+9900.0%) | $7.97 M(+130.2%) | $11.80 M(+207.8%) |
| Sept 2020 | - | $3.46 M(+830.4%) | $3.83 M(+930.4%) |
| June 2020 | - | $372.00 K(+1966.7%) | $372.00 K(+23.6%) |
| Dec 2019 | $18.00 K(-98.4%) | - | - |
| June 2019 | - | $18.00 K(-93.6%) | $301.00 K(-79.3%) |
| Dec 2018 | $1.13 M(-86.2%) | - | - |
| Sept 2018 | - | $283.00 K(-22.3%) | $1.46 M(-83.8%) |
| June 2018 | - | $364.00 K(-24.3%) | $8.98 M(+4.2%) |
| Mar 2018 | - | $481.00 K(+47.1%) | $8.62 M(+5.7%) |
| Dec 2017 | $8.16 M(-53.5%) | $327.00 K(-95.8%) | $8.16 M(-67.8%) |
| Sept 2017 | - | $7.81 M(>+9900.0%) | $25.36 M(+44.5%) |
| Mar 2017 | - | $19.00 K(-99.9%) | $17.55 M(+0.1%) |
| Dec 2016 | $17.53 M | $17.53 M | $17.53 M |
FAQ
- What is UroGen Pharma annual revenue?
- What is the all time high annual revenue for UroGen Pharma?
- What is UroGen Pharma annual revenue year-on-year change?
- What is UroGen Pharma quarterly revenue?
- What is the all time high quarterly revenue for UroGen Pharma?
- What is UroGen Pharma quarterly revenue year-on-year change?
- What is UroGen Pharma TTM revenue?
- What is the all time high TTM revenue for UroGen Pharma?
- What is UroGen Pharma TTM revenue year-on-year change?
What is UroGen Pharma annual revenue?
The current annual revenue of URGN is $82.71 M
What is the all time high annual revenue for UroGen Pharma?
UroGen Pharma all-time high annual revenue is $82.71 M
What is UroGen Pharma annual revenue year-on-year change?
Over the past year, URGN annual revenue has changed by +$18.36 M (+28.52%)
What is UroGen Pharma quarterly revenue?
The current quarterly revenue of URGN is $25.20 M
What is the all time high quarterly revenue for UroGen Pharma?
UroGen Pharma all-time high quarterly revenue is $25.20 M
What is UroGen Pharma quarterly revenue year-on-year change?
Over the past year, URGN quarterly revenue has changed by +$4.35 M (+20.87%)
What is UroGen Pharma TTM revenue?
The current TTM revenue of URGN is $89.36 M
What is the all time high TTM revenue for UroGen Pharma?
UroGen Pharma all-time high TTM revenue is $89.36 M
What is UroGen Pharma TTM revenue year-on-year change?
Over the past year, URGN TTM revenue has changed by +$12.09 M (+15.64%)